Actively Recruiting
Study on Quality of Life in Adults with Asymptomatic Monoclonal Gammopathies including MGUS and Smoldering Multiple Myeloma
Led by M.D. Anderson Cancer Center · Updated on 2026-04-15
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to understand the quality of life and related anxiety in patients with monoclonal gammopathy of unknown significance MGUS and smoldering multiple myeloma SMM. By collecting quality of life information, the study seeks to identify common symptoms and patient concerns to help guide future treatments or preventive measures. Participants are patients already enrolled in clinical trials at MD Anderson Cancer Center. Participants complete quality of life questionnaires either every six months if in an observational study or monthly if in a treatment study, for up to three years. These questionnaires take about 10 to 15 minutes to complete and help assess patients experiences living with MGUS or SMM. Throughout the study, patients provide information via these questionnaires at baseline and scheduled intervals. Researchers use this data to monitor quality of life and anxiety related to their condition. The primary outcome is the results from these questionnaires collected over up to three years, helping to better understand patient needs and concerns.
CONDITIONS
Brief Title
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Research Team
M
Melody Becnel, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
